Finance beat

Earnings

The Earnings beat on Finance tracks 636 verified stories, with 2 clearing multi-source corroboration in the last 7 days at mean impact 7/10 — live SQLite counts, not editorial weighting.

50 stories

Beat pulse

Last 7 days · Earnings

→
2 stories
7 avg impact
50% positive
50% negative
vs prior 7 days -2 -2 stories vs prior 7 days

Impact 7.0/10 (+1.5 vs prior). Counts are stories in our record, not a market forecast.

Open the change report

Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.

  • 50% positive
  • 50% negative

Stories appear on this page because our classification stage assigned them this category as their primary topic — each story receives exactly one category per niche, chosen from a fixed list, so a story that touches both a funding round and a product launch in the same week sorts into whichever category best matches its dominant subject, not both. This keeps each category page focused on one beat rather than a blend of unrelated developments, and applies the same source-verification standard used across every story on this site. Sentiment measures the directional read of each development for this category specifically, not the tone of the reporting, and impact weights how consequential a development is — regulatory, financial, or operational — rather than how widely it was syndicated across outlets.

Figures are computed live from our source-verified story record (as of ) The volume change compares this window with the prior 7 days in the same record. — see our methodology for how impact and sentiment are derived.

Beat actors

Who drives Earnings

Entities appearing in at least two verified earnings stories on this desk — ranked by mention count, not editorial preference.

Neutral 5

Costco’s Premium Valuation Faces Scrutiny Amid Sustained Growth Momentum

Costco continues to deliver robust top-line growth and membership retention, yet its soaring valuation has sparked a debate among analysts regarding its risk-reward profile. While the retailer's membership-driven model provides a defensive moat, the current price-to-earnings multiple sits significantly above historical averages and industry peers.

Verified by 2 sources
Neutral 5

Algonquin Power Pivots to Pure-Play Utility Model with 2026-2027 Guidance

Algonquin Power & Utilities has updated its fiscal year 2026 earnings outlook and issued its inaugural 2027 guidance, marking a definitive shift toward a regulated utility model. The new projections follow the company's massive $2.5 billion divestiture of its renewable energy portfolio to LS Power.

Verified by 2 sources
Neutral 5

Micro-Cap Execution: Acorn Energy and CorMedix Deliver Q4 2025 Results

Acorn Energy and CorMedix both reported Q4 2025 financial results on March 5, 2026, marking a critical transition from development to commercial scaling. While Acorn focuses on high-margin IoT recurring revenue, CorMedix is navigating the complex rollout of its lead product, DefenCath, in the dialysis market.

Verified by 2 sources
Neutral 5

Stratasys Signals Industrial Pivot Success in Q4 2025 Earnings Call

Stratasys Ltd. reported Q4 2025 results that underscore a successful transition toward high-margin industrial production and recurring consumables revenue. Despite broader macroeconomic headwinds affecting capital equipment spending, the company achieved significant margin expansion and reaffirmed its leadership in the additive manufacturing sector.

Verified by 2 sources

Source: insidermonkey.com · fool.com

Very Bullish 7

Palantir Surges as Wall Street Applauds Strategic Moat and Global AI Expansion

Palantir Technologies received a significant vote of confidence from Wall Street analysts following a series of strategic victories, including a potential competitive advantage in Pentagon contracts and high-level diplomatic engagements in Japan. The bullish sentiment underscores Palantir's unique position as the primary software layer for both defense and commercial AI applications.

Verified by 2 sources

Source: fool.com · fool.com

Neutral 5

Kura and Profound Signal Commercial Inflection Points in Q4 Results

Kura Oncology and Profound Medical reported Q4 2025 results, highlighting a pivotal shift toward commercial execution. Kura is nearing an NDA submission for its lead leukemia candidate, while Profound saw record revenue growth following the first full year of Category 1 CPT code implementation.

Verified by 2 sources
Neutral 5

Profound Medical and OptimizeRx Post Strong 2025 Results as Med-Tech Scales

Profound Medical and OptimizeRx reported robust fourth-quarter and full-year 2025 financial results, signaling a significant uptick in the adoption of MRI-guided interventions and digital life sciences engagement. The reports highlight a broader recovery in healthcare technology spending and a shift toward precision-based medical outcomes.

Verified by 2 sources
Bullish 6

AI and Specialized Hardware Drive Record Q4 Performance for Mid-Cap Tech

A diverse group of mid-cap companies, including fintech leader Dave and hardware innovator Quantum Computing, reported strong Q4 2025 results characterized by AI-driven margin expansion and strategic pivots toward high-value services. These reports underscore a broader market trend where specialized technology integration is finally translating into consistent profitability and record-breaking revenue growth.

Verified by 4 sources
Bearish 7

JD.com Records First Quarterly Loss Since 2022 Amid Delivery Price War

JD.com reported a 2.7 billion yuan net loss for Q4 2025, driven by a massive 75% surge in annual marketing spend to compete in China's food delivery sector. Despite the bottom-line hit, the company achieved a 15% market share in delivery and expects investment intensity to taper in 2026.

Verified by 3 sources
Bullish 8

UBS Sets $245 Nvidia Target as $100B Quarterly Revenue Becomes Reality

UBS has reiterated a strong Buy rating on Nvidia with a $245 price target following a record-breaking fiscal fourth quarter and massive forward guidance. The firm's bullishness stems from accelerating data center demand and the arrival of the 'agentic AI' era, which is driving inventory commitments to unprecedented levels.

Verified by 2 sources

Source: Miamiherald · Sacbee

Bullish 6

Q4 Earnings: Automation and Energy Tech Surge as Ad-Tech and Retail Stabilize

The final quarter of 2025 highlights a stark divergence in corporate performance, with industrial automation and next-generation energy technology outperforming traditional retail and advertising sectors. While companies like Amprius and Ranpak report triple-digit growth and automation breakthroughs, others are aggressively rationalizing operations to protect margins amidst shifting demand.

Verified by 8 sources
Neutral 5

Guidewire Software Surges as Q4 Sales Beat Estimates, Defying Sector Headwinds

Guidewire Software reported Q4 CY2025 sales that topped analyst estimates, providing a strong rebuttal to recent analyst downgrades and insider selling concerns. The results highlight the accelerating adoption of Guidewire Cloud, bolstered by major international deals like the Sompo Group expansion.

Verified by 2 sources
Neutral 5

CooperCompanies and Rumble Deliver Steady Q4 Results Amid Market Volatility

CooperCompanies and Rumble both reported fourth-quarter 2025 financial results that met analyst expectations, signaling operational stability in the medical device and digital media sectors. While both firms navigated macroeconomic headwinds, their ability to hit consensus targets provides a floor for investor sentiment heading into the 2026 fiscal year.

Verified by 2 sources
Neutral 5

Small-Cap Earnings Pulse: Evolus and QuickLogic Lead Diverse Sector Growth

The Q4 2025 earnings season for small-cap leaders reveals a resilient performance across the aesthetics, semiconductor, and industrial sectors. While Evolus continues to capture market share in the neurotoxin space, QuickLogic is leveraging significant new defense contracts to drive its high-reliability FPGA business.

Verified by 4 sources
Neutral 5

Rumble and Mid-Cap Tech Leaders Report Q4 2025 Earnings Amid Sector Shifts

A cluster of mid-cap and small-cap companies, led by Rumble and Atea Pharmaceuticals, released fourth-quarter and full-year 2025 results, signaling a period of strategic transition. The reports highlight a divergence between high-growth digital infrastructure and the clinical-stage healthcare sector as firms navigate the post-2024 economic landscape.

Verified by 5 sources
Neutral 5

Canadian REITs Signal Resilience: Automotive and PRO REITs Report Q4 Growth

Automotive Properties REIT and PRO REIT reported Q4 2025 results, highlighting stable occupancy and rent growth despite a challenging interest rate environment. The results underscore the defensive nature of specialized automotive real estate and the ongoing strength of the Canadian industrial sector.

Verified by 2 sources
Neutral 5

AI Infrastructure and Retail Resilience Anchor High-Stakes Earnings Week

Major earnings reports from Broadcom and Costco highlight a dual-track market narrative driven by aggressive AI infrastructure spending and steady consumer demand. Broadcom’s bullish $100 billion AI revenue forecast for 2027 has set a high bar for the semiconductor sector, while Costco’s membership growth remains a critical barometer for retail health.

Verified by 2 sources

Source: Seeking Alpha · Seeking Alpha

Bullish 6

Ciena and CPI Card Group Outperform on Strong FY26 Outlooks and Earnings Beats

Networking leader Ciena and payment solutions provider CPI Card Group both exceeded analyst expectations for the first quarter, signaling robust demand in infrastructure and fintech. Ciena notably raised its full-year 2026 guidance, reflecting confidence in the ongoing global expansion of optical networking and AI-driven data center demand.

Verified by 2 sources

Source: Seeking Alpha · Seeking Alpha

Neutral 5

Specialty Pharma Resilience: Cumberland and Rigel Navigate Q4 Headwinds

Cumberland and Rigel Pharmaceuticals reported Q4 2025 results, highlighting strategic shifts toward high-margin specialty products and oncology expansions. While Cumberland focuses on hospital-channel optimization, Rigel is doubling down on its hematology-oncology portfolio to drive long-term growth.

Verified by 2 sources
Bullish 6

Palladyne AI and Burlington Surpass Estimates as FY26 Outlooks Solidify

Palladyne AI and Burlington Stores both delivered strong quarterly performances, exceeding analyst expectations on both revenue and earnings. While Palladyne AI reaffirmed its long-term trajectory for fiscal 2026, Burlington introduced a robust new guidance framework, signaling confidence in the off-price retail and AI software sectors.

Verified by 2 sources
Neutral 5

OmniAb and PepGen Q4 Results Highlight Divergent Biotech Growth Strategies

OmniAb and PepGen reported full-year 2025 results, showcasing the health of the antibody discovery and neuromuscular therapeutics sectors. While OmniAb focuses on platform scalability and royalty streams, PepGen emphasizes clinical execution and cash preservation for its lead candidates.

Verified by 2 sources
Bullish 6

SaaS Resilience: Okta Hits $3B Milestone as Ooma Pivots to Enterprise

Okta and Ooma both reported strong Q4 2026 results, highlighting a broader sector trend of shifting toward higher-margin enterprise services and AI integration. While Okta surpassed the $3 billion annual contract value milestone, Ooma successfully integrated key acquisitions to accelerate its transition from residential to business-centric revenue.

Verified by 2 sources
Neutral 5

Daktronics Q3 2026 Earnings: Revenue Surges 22% as MLB Projects Drive Growth

Daktronics, Inc. reported a 21.6% increase in sales to $181.9 million for its fiscal 2026 third quarter, successfully swinging from a prior-year operating loss to a $1.9 million profit. The company's performance was bolstered by a 25% surge in product backlog, reaching $342.3 million, driven by major sports stadium installations and improved operational efficiencies.

Verified by 4 sources

Source: Globenewswire_fr · Benzinga

Bullish 6

Stem Achieves First Profitable Year as Software Pivot Drives Record Margins

Stem (STEM) reached a critical financial milestone in Q4 2025, reporting its first full year of positive adjusted EBITDA and operating cash flow. The results highlight a successful strategic pivot toward high-margin software and services, which now account for over half of total revenue.

Verified by 14 sources
Neutral 5

ImmuCell and Pinetree Capital Reveal 2025 Results Amid Scaling Shift

ImmuCell (ICCC) has issued its preliminary 2025 financial results, highlighting a year of operational scaling for its bovine immunity products. Simultaneously, major shareholder Pinetree Capital Ltd released audited figures and expanded its board, signaling a period of strategic consolidation for the animal health biotech and its primary backer.

Verified by 2 sources
Neutral 5

Asana and AST SpaceMobile Signal Growth Shifts in Q4 Earnings Reports

Asana, Inc. and AST SpaceMobile, Inc. released quarterly results highlighting divergent paths in the SaaS and space telecommunications sectors. While Asana navigates a maturing market with AI-driven enterprise tools, AST SpaceMobile continues its capital-intensive push toward global satellite connectivity.

Verified by 2 sources
Very Bullish 6

Datadog and agilon health Surge as Growth Narratives Re-Accelerate

Datadog and agilon health shares experienced significant rallies on March 4, 2026, signaling a robust appetite for high-growth cloud infrastructure and value-based healthcare models. The moves highlight a broader market shift toward companies demonstrating both scale and operational leverage in complex regulatory and technological environments.

Verified by 2 sources
Neutral 5

Earnings Divergence: Real Brokerage Scales Up as Rayonier Faces Widening Losses

The Real Brokerage Inc. (REAX) reported continued agent expansion and revenue growth in Q4 2025, while Rayonier Advanced Materials (RYAM) struggled with a widening net loss and ongoing debt restructuring. These results highlight a stark contrast between high-growth tech-enabled real estate platforms and legacy industrial materials firms facing margin pressure.

Verified by 2 sources
Neutral 5

Small-Cap Earnings Spotlight: Lexicon and Ituran Navigate Q4 Inflection Points

Investors are bracing for Q4 2025 results from Lexicon Pharmaceuticals and Ituran Location, two small-cap players facing critical operational milestones. While Lexicon seeks to prove the commercial viability of its heart failure treatment, Ituran aims to capitalize on expanding telematics demand in emerging markets.

Verified by 2 sources
Neutral 5

MedTech Earnings: 908 Devices and Strata Critical Medical Signal Diagnostic Shift

908 Devices Inc. and Strata Critical Medical reported Q4 2025 results, highlighting a strategic pivot toward decentralized diagnostics and bioprocessing efficiency. Both companies emphasized recurring revenue growth from consumables as they navigate a complex capital equipment environment.

Verified by 2 sources
Neutral 5

L.B. Foster Hits 7-Year Sales Peak as Infrastructure Tech Pivot Drives Profits

L.B. Foster Company reported its strongest fourth-quarter net sales since 2018, marking a significant milestone in its multi-year transition toward high-margin technology solutions. The results highlight robust profitability growth and operating cash flow, signaling a successful pivot from legacy commodity products.

Verified by 2 sources
Bullish 6

AI Sector Bifurcation: BigBear.ai Struggles as Vertiv Reaches Peak Valuation

Recent earnings reports reveal a widening gap in the AI sector between speculative software plays and essential infrastructure providers. While BigBear.ai faces significant revenue declines and persistent cash burn, Vertiv continues to ride the data center wave, though its stock now appears priced for perfection.

Verified by 2 sources
Bullish 6

Growth Divergence: On Holding and Sportradar Surge as Quanterix Pivots

A wave of Q4 2025 earnings reports reveals a stark performance gap between high-margin consumer platforms and specialized technology firms. While On Holding and Sportradar delivered record margins and aggressive capital returns, Quanterix and BigBear.ai faced organic declines despite achieving critical regulatory and liquidity milestones.

Verified by 6 sources
Neutral 5

Consumer Resilience Tested as Best Buy and Paysafe Post Mixed Q4 Results

Best Buy and Paysafe both reported fourth-quarter results that highlighted a complex consumer landscape, characterized by disciplined spending and shifting demand cycles. Both companies issued 2026 guidance that emphasizes operational efficiency and a strategic pivot toward high-margin services and specialized digital payments.

Verified by 2 sources
Bullish 6

Mobility Sector Resilience: Thor and EVgo Deliver Strong Earnings Beats

Thor Industries and EVgo have both exceeded analyst expectations for the most recent quarter, signaling robust demand in both the recreational vehicle and electric vehicle infrastructure markets. While Thor reaffirmed its existing long-term targets, EVgo’s introduction of its first FY26 outlook suggests a pivotal shift toward operational maturity and predictable growth.

Verified by 2 sources
Neutral 5

Plug Power Q4 Loss Narrows as Green Hydrogen Strategy Gains Operational Traction

Plug Power reported a narrowing loss per share for the fourth quarter, signaling a potential turning point in its multi-year effort to stabilize margins. The results reflect the company's transition toward internal hydrogen production and more disciplined capital allocation amid a challenging macro environment.

Verified by 2 sources
Bullish 7

IonQ Shares Rocket 23% as Q4 Revenue Surges 429% on Commercial Adoption

IonQ reported a massive fourth-quarter earnings beat, driven by a 429% year-over-year revenue surge and a significant shift toward commercial adoption. The company's optimistic 2026 guidance suggests that quantum computing is rapidly moving from experimental phases into a viable enterprise market.

Verified by 3 sources
Neutral 5

Biotech Execution in Focus: Arcturus and Rigel Set for Q4 Earnings Results

Arcturus Therapeutics and Rigel Pharmaceuticals are preparing to report Q4 2025 results, highlighting a pivotal shift from clinical development to commercial execution. Investors are focused on Arcturus's mRNA vaccine rollout in Japan and Rigel's integration of its expanded oncology portfolio.

Verified by 2 sources

About Finance Earnings coverage

According to our own tracking database, this category has accumulated 636 earnings stories since coverage began. This page aggregates the latest earnings stories within our finance coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track quarterly results, guidance, estimates and surface the angles a domain expert would actually read.

Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the finance beat.

Stories only surface on this page once the classifier scores them at a minimum 35 percent relevance to the category. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong on this page — a wrong stat, a broken source link, a miscategorized story? Report a data issue.

SignalWhat it tells you
Verified by N sourcesConfidence the story isn't a single-source rumor — N≥2 means the development is independently corroborated.
Impact score (1-10)Estimated regulatory, financial, or operational impact. 8+ indicates a story experienced operators should act on.
SentimentFive-tier classification (very bullish through very bearish) trained on labeled finance-specific corpora.
Time stampRecency. Fresh stories (under 1h) render with a highlighted timestamp; stale stories (≥24h) render dimmed.